Open Ledger
Novo Nordisk financials in Beancount
Novo Nordisk keeps 5 recorded periods through FY2026H1 as a balanced Beancount ledger — inspect the figures below, then open the live books.
Updated
Latest figures
- Revenue
- DKK 175.3B (175,311 MDKK)
- Net income
- DKK 69.5B (69,546 MDKK)
- Net margin
- 39.7%
Recorded history
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2022 | December 31, 2022 | DKK 177B (176,954 MDKK) | DKK 55.5B (55,525 MDKK) |
FY2023 | December 31, 2023 | DKK 232.3B (232,261 MDKK) | DKK 83.7B (83,683 MDKK) |
FY2024 | December 31, 2024 | DKK 290.4B (290,403 MDKK) | DKK 101B (100,988 MDKK) |
FY2025 | December 31, 2025 | DKK 309.1B (309,064 MDKK) | DKK 102.4B (102,434 MDKK) |
Recorded revenue and net income in MDKK (Half-year periods).
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2026H1 | June 30, 2026 | DKK 175.3B (175,311 MDKK) | DKK 69.5B (69,546 MDKK) |
Coverage
Coverage5
FY2022FY2023FY2024FY2025FY2026H1
Earnings analyses
More companies in this sector
- Hims HersHims & Hers Q2 2026 Earnings: Revenue Up 38% to $753M as GAAP Swings to an $86M Loss
- MedtronicMedtronic FY2027 Q1 Earnings: $9.76B Revenue, a 53-Week Calendar, and Cardiac Ablation at +88%
- Eli LillyEli Lilly Q2 2026 Earnings: $12.2 Billion Quarter and $85–87 Billion Guide as GLP-1 Royalty Compounds